Cinctive Capital Management’s Verona Pharma VRNA Stock Holding History

Cinctive Capital Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-221,054	Closed	-$23.6M	–	532
2025 Q3	$23.6M	Buy	221,054 +161,400	+271%	+$16.9M	1.13%	11
2025 Q2	$5.64M	Sell	59,654 -5,721	-9%	-$424K	0.3%	111
2025 Q1	$4.15M	Buy	+65,375	New	+$3.91M	0.32%	101

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Cinctive Capital Management's VRNA Position: Q4 2025 in Review

Cinctive Capital Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 221,054 shares — an estimated $23.6M sold.

Cinctive Capital Management first reported a position in VRNA in Q1 2025 and held it in 3 quarters. The position peaked at $23.6M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Cinctive Capital Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Cinctive Capital Management sold 221,054 Verona Pharma shares in Q4 2025, an estimated $23.6M.
Cinctive Capital Management first reported a position in Verona Pharma in Q1 2025 and held it in 3 quarters.
Cinctive Capital Management's Verona Pharma position peaked at $23.6M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Cinctive Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.